Dexcom (DXCM) Treasury Shares (2018 - 2026)

Dexcom (DXCM) has reported Treasury Shares for 9 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares rose 72.53% year-over-year to $2.7 billion in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 72.53% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 31.85% from the prior year.
• Treasury Shares was $2.7 billion for Q2 2026 at Dexcom, up from $2.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $35.0 million in Q2 2026 and troughed at $100000.0 in Q1 2022.
• A 5-year average of $15.1 million and a median of $18.2 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 62.7% in 2022 and surged 2002.14% in 2023, its largest moves.
• Over 5 years, Treasury Shares stood at $595.0 million in 2022, then surged by 311.95% to $2.5 billion in 2023, then tumbled by 35.49% to $1.6 billion in 2024, then surged by 31.85% to $2.1 billion in 2025, then surged by 30.85% to $2.7 billion in 2026.
• The last three Treasury Shares figures came in at $2.7 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.